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Abstract
Closure of the ductus arteriosus (DA) is a crucial step in the transition from fetal to postnatal life. Patent DA is one of the
most common cardiovascular anomalies in children with significant clinical consequences especially in premature infants.
We aimed to identify genes that specify the DA in the fetus and differentiate it from the aorta. Comparative microarray
analysis of laser-captured microdissected endothelial (ECs) and vascular smooth muscle cells (SMCs) from the DA and aorta
of fetal rats (embryonic day 18 and 21) identified vessel-specific transcriptional profiles. We found a strong age-dependency
of gene expression. Among the genes that were upregulated in the DA the regulator of the G-protein coupled receptor 5
(Rgs5) and the transcription factor distal-less homeobox 1 (Dlx1) exhibited the highest and most significant level of
differential expression. The aorta showed a significant preferential expression of the Purkinje cell protein 4 (Pcp4) gene. The
results of the microarray analysis were validated by real-time quantitative PCR and immunohistochemistry. Our study
confirms vessel-specific transcriptional profiles in ECs and SMCs of rat DA and aorta. Rgs5 and Dlx1 represent novel
molecular targets for the regulation of DA maturation and closure.
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Introduction
The ductus arteriosus (DA) is a highly specialized fetal blood
vessel that connects the pulmonary trunk with the descending
aorta. In the fetal circulation the DA bypasses the fluid-filled lungs
by shunting blood from the pulmonary trunk into the systemic
circulation. At birth, with the transition from placental oxygen
supply to air breathing, this connection becomes unnecessary and
closes. DA closure is a crucial step in the transitional circulation as
it ensures the efficient delivery of oxygenated blood from the lungs
to all organs. Failure of DA closure leads to one of the most
common cardiovascular anomalies in children causing morbidity
and mortality especially in premature infants. [1,2] Inhibition of
DA closure on the other hand is critical for the immediate
postnatal survival of infants with various types of severe structural
heart disease. [3] Although sharing the same embryologic origin
and environment the DA shows a unique development and
differentiation compared with other pharyngeal arch artery
derivatives in rats and many other species. [4,5] In the chick
embryo the DA acquires its typical muscular morphology while
the adjoining aorta differentiates into an elastic vessel by elastin
deposition and concomitant loss of actin expression in the media.
[5] Already in the second trimester of human gestation the DA
media is composed of highly differentiated vascular smooth muscle
cells (SMCs) [6] compared to the aorta. From the second trimester
of pregnancy onwards endothelial cells (ECs) and SMCs in the
inner part of the DA undergo a ductus-specific remodeling
process. [7] As a result of this process the mature DA exhibits
intimal thickening, which facilitates sealing of the constricting
vessel immediately after birth. Early (functional) closure of the DA
is triggered by the postnatal increase of oxygen partial pressure
and decrease in prostaglandin. [8] The contraction in response to
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oxygen is intrinsic to the SMCs of the DA and highly conserved
among different species. Oxygen-induced inhibition of voltage-
gated K+ channels, activation of L-type voltage-gated calcium
channels, increased endothelin synthesis and redox-dependent
activation of ROCK [9] and other calcium sensitization pathways
[10] have been documented in the DA of humans and rabbits.
After the functional closure the definitive anatomical closure of the
DA is initiated. In the subsequent postnatal period the DA
degenerates due to cytolytic necrosis and apoptosis of the muscular
artery into a fibrous remnant, [11] while the adjoining elastic
vessels remain open.
Although various anatomical, physiological and biochemical
aspects of DA closure have been studied during the last decades
reviewed in Bo¨kenkamp et al. [8] little is known about the
molecular mechanisms controlling the unique remodeling process
of the DA. A recent study documented the expression of the
truncated lamin A protein ‘‘progerin’’, the underlying cause of
Hutchinson Gilford Progeria syndrome, related to the cytolytic
necrosis process in the DA. This finding suggests involvement of
alternative splicing of lamin A (LMNA) in the vascular remodeling
of the normal neonatal DA [12].
Human disease states offer insights into the transcriptional
regulation of certain physiological processes. Regarding DA
closure Char syndrome and patent DA in preterm infants are
instructive. The patent DA and mild facial and hand anomalies in
Char syndrome are caused by mutations in the neural crest-related
transcription factor AP2B gene (TFAP2B). [13] Sequence
polymorphisms in the same gene are associated with isolated
non-syndromic patent DA in preterm infants [14–16] and
consequently suggest a role for Tfap2B in the transcriptional
control of normal DA closure. Targeted deletions of Tfap2B in
mice confirm the critical role of Tfap2B in DA development and
limb patterning [17,18].
Two previous studies on transcriptional profiles of the DA and
aorta in fetal rats revealed characteristic differences between both
vessels. [19,20] These studies are hardly comparable [21] as one
was aimed to ascertain changes in in aorta and DA linked to birth
and oxygen action [19] and the other addressed the issue of the
relative predominance of transcripts in the DA versus the aorta
antenatally. [20] Upregulation of sarcomeric genes, characteristic
for the fetal DA in the study of Costa et al. [19] was found in the
aorta by Jin et al. [20]. Growth hormone receptor (Ghr) exhibited
the most significant upregulation in the DA among all DA-specific
genes in the study of Jin et al. [20] but was not differentially
expressed in the dataset of Costa et al [19.] Both studies used
pooled whole vessel preparations of DA and aorta from two
different strains of rats (i.e.,Wistar [19] and Long-Evans [20]) for
the microarray analysis.
In microarray analyses of whole vessel extracts the specific role
of different cell populations, i.e., ECs and SMCs of the DA and
descending aorta, cannot be determined. We have chosen a more
selective technique. Laser-captured microdissected cells offer the
opportunity to study gene expression profiles in neighboring cells
of different embryonic origin. By analyzing the profiles from late
fetal (day 18) and near term (day 21) rats we were able to study the
change in ECs and SMCs during the DA remodeling process at
late gestation. We hypothesized that both cell types of the DA and
aorta would have distinct transcriptional profile characterizing the
artery that will close after birth and the neighboring vessel that will
remain open for the duration of life. We further hypothesized that
transcriptional profiles in ECs and SMCs from DA and aorta
would reflect either a different origin or function of these cells,
which might be detected in the perinatal period accompanying the
radical changes of environment and phenotype.
Methods
1. Animals
Pups from 6 timed–pregnant Wistar rats were delivered after
respectively 18 and 21 days of gestation (spontaneous birth occurs
at 22 days of gestation) by hysterotomy through a median
abdominal incision. For the time of delivery the dams were
anesthesized with sevofluorane 2.5% in room air; subsequently the
dams were euthanized. Care was taken to keep the time between
the delivery of the first and the last pup within 5 minutes. The litter
size was approximately 12 pups per dam. Out of these 12 the first
3 pups were used for the microarray experiment. Isolation of the
fetal thorax was carefully performed in RNase free conditions,
frozen in Tissue Tek (Sakura Finetek USA, Torrance, CA, USA),
and stored at 280uC. Figure 1 shows the experimental design,
which was used at both day 18 and day 21 of gestation. The
feasibility of the experiments was tested in a separate pilot
experiment using 4 Wistar rat embryos from two dams after 21
days gestation. Data from the pilot experiment are presented in
Figures S1 and S2.
2. Ethics Statement
Both experiments were approved by an independent Institu-
tional Animal Care and Use committee at the LUMC in
accordance with the Helsinki convention for the use and care of
laboratory animals.
3. Laser-capture Microdissection
Cryostat sections (8 mm) were attached to RNase free (Super-
frost TM) microscopic slides and immediately placed on dry ice.
The slides were preserved in 280uC conditions. Three slides of
each embryo were immunohistochemically stained in one batch.
RNase free PBS was used for the appropriate dilution of antibodies
and washing steps. Furthermore, Superase. In (AM2696, Ambion,
Austin, TX, USA) was added to the diluted antibody solution
(1 U/mL). After fixation in cold acetone (4uC) for 2 minutes, cold
(4uC) conditions were maintained during further immunohisto-
chemical staining. The three slides could easily be air-dried after
acetone fixation. 30 mL of cold PBS was applied to each tissue
section and drained off. In subsequent order, 30 mL of Biotin-
conjugated mouse anti-rat CD31 (BD 555026) (5 mg/100 ul), Cy3
Streptavidin (1:100) Streptavidin Cy3 (HistoGeneH Cy3H strepta-
vidin) taken from HistogeneH LCM Immunofluorescence Staining
Kit KIT0420(Applied Biosystems, Foster City CA, USA) and
alpha smooth muscle actin antibody (1A4) FITC (Abcam ab8211)
(1 mg/30 mL) were applied. In order to further limit RNase
activity, each antibody solution was only applied for 2 minutes.
Subsequently, the antibody was gently drained off with 200 mL of
cold PBS. The slides were dehydrated at room temperature in
75% EtOH (30 sec), 95% EtOH (30 sec), 100% EtOH (30 sec),
100% EtOH (120 sec), xylene (180 sec). Dehydration was
immediately followed by laser capture microdissection (LCM)
(Veritas Microdissection Instrument, Arcturus Bioscience Inc.,
Mountain View, CA, USA). 100 to 200 cells from three tissue
sections were dissected from the DA and descending aorta of each
embryo. ECs were defined as cells lining the lumen and staining
positive for anti-rat CD31. Alpha-smooth muscle actin positive
cells were identified as SMCs. (Figure 2) The microdissected cells
were transferred to a Gene Amp tube (Applied Biosystems, Foster
City CA, USA) containing 75 mL of Rneasy lysis buffer (RLT;
Qiagen, Hilden, Germany) containing 0.14 M beta-mercaptoeth-
anol and 200 ng Polyinosinic Acid (Sigma Aldrich, USA). The
samples were incubated at 42uC for20 minutes and stored at
280uC.
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4. RNA Isolation, Amplification, Labeling, and Microarray
Hybridization
The 48 laser-captured samples were processed simultaneously
after thawing. From each of the 6 parallel samples (Figure 1) RNA
was isolated, cleaned up and eluted separately in 14 mL of RNase-
free water according to the RNeasy Minelute protocol (Qiagen,
Hilden, Germany). Two rounds of linear mRNA amplification
were performed (modified Eberwine protocol): two-cycle cDNA
synthesis and synthesis of biotin-labeled aRNA was performed
according to the GeneChip Eukaryotic Sample and Array
Processing Manual (Affymetrix, Santa Clara, CA, USA).
MEGAscript T7 kit (Ambion, Austin, TX, USA) was used for
in vitro transcription of the second cDNA strand in the first round
of amplification. The second round of amplification, starting from
100 ng of first round aRNA, was finalised during the GeneChip
in vitro transcription (IVT) labelling. Despite immunohistochemic
double-staining and laser-capture dissection sufficient amounts of
RNA could be isolated from these cells and amplified for the
microarray experiment. (see Table S1) Two-round linear mRNA
amplification yield). Labeled RNA was hybridized to the
GeneChip Rat Genome 230 2.0 Array. Hybridization was
performed using 12.5 mg of biotin-labeled RNA at 45uC for 16
hours under continuous rotation. Arrays were stained in
Figure 1. Flowchart showing the experimental design for fetal rats at day 18. The fetal rats were delivered from 2 dams. LCM= laser-
capture microdissection, AO EC= endothelial cells from the descending aorta, AO SMC= smooth muscle cells from the descending aorta, DA
EC= endothelial cells from the ductus arteriosus, DA SMC= smooth muscle cells from the ductus arteriosus, PFA 4%=paraformaldehyde 4%,
LCM= laser-capture microdissection, MA=microarray. The same experimental design was used for the experiments at day 21.
doi:10.1371/journal.pone.0086892.g001
Figure 2. Sections used for laser-capture microdissection. The level of laser-capture microdissection (LCM level) is indicated in a and d. The
arrow represents the area of LCM in the aorta (AO) of a fetal rat at 18 days (18 d) and the ductus arteriosus (DA) at 21 days (21 d). Smooth muscle cells
are labeled with anti-smooth muscle actin in green (b, f) and endothelial cells are labeled with CD31 in red (c,g). Bars represent 100 mm. Images from
the microdissection cap show the dissected endothelium of two aorta sections with fluorescence (d) and strips of SMCs from the DA without
fluorescence (h). These photomicrographs are taken from the microdissection cap that was used for capturing the tissue samples from the sections.
doi:10.1371/journal.pone.0086892.g002
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Affymetrix Fluidics stations using streptavidin-phycoerythrin
(SAPE), followed by staining with anti-streptavidin antibody and
a second SAPE staining. Subsequently, arrays were scanned with
an Agilent Laserscanner (Affymetrix, Santa Clara, CA, USA).
5. Real Time Quantitative PCR Analysis
First-strand cDNA synthesis was performed on 1 mg of the 2rnd
linear amplification cRNA from the microdissected cells using
random hexamer primers and Superscript III RT (Invitrogen,
Grand Island, NY, USA) in a total reaction volume of 20 mL
during 1 h at 50uC. This was followed by inactivation of the
enzyme at 70uC for 15 min (Invitrogen, Carlsbad, USA).
Quantitative PCR (qPCR) was performed on an ABI Prism
7900-HT Sequence Detection System (Applied Biosystems,
Carlsbad, USA). The total PCR reaction volume was 10 mL.
The reaction mix was prepared using a qPCR Core kit
(Eurogentec RT-QP73-05). The concentrations of each dNTP
and MgCl2 were 200 mM and 5 mM respectively. A final dilution
of 300 nM of the forward and reverse primer and 100 nM dilution
of the probe of each assay were utilized in the reaction mix. 10 ng
cDNA of each sample was used in the PCR reaction. 20 ng of
whole embryonic rat cDNA was serially diluted (1X, 4X, 16X,
64X, 256X, 1024X) for the construction of a standard curve for
each assay. A duplicate of each PCR reaction was performed. The
thermal cycling conditions were 10 min at 95uC, followed by 45
cycles of 15 s at 95uC and 1 min at 60uC. Validated pre-designed
Taqman Gene Expression Assays (Applied Biosystems, Carlsbad,
USA) corresponding to the housekeeping genes Pgk1
(Rn00821429_g1) and Ppib (Rn00574762_m1) were used to
generate standard curves on serial dilutions of cDNA. The
standard curve method was used to calculate the relative quantity
of each gene expressed in the tissue samples. Relative expression
values of Dlx1, Rgs5, Pcp4, vWF and Tfap2B were normalized with
housekeeping genes Pgk1 and Ppib. Linear regression (least squares)
and robust regression were applied for the construction of
calibration curves. Robust regression [22) gives less weight to
large observations (for high variant replicates). GraphPad Prism 5
(GraphPad Software, Inc., La Jolla, USA) and the lmrob function
in the ‘Robustbase Package’ in R (http://www.inside-r.org/
packages/cran/robustbase/docs/.vcov.avar1) were used for visu-
alization and statistical analysis. In the figures data are presented
as means with standard errors of the mean (SEM). Details of each
assay, Y-intercept and slope (linear and robust regression) and
calibration curve (robust regression) are provided in Table S2.
This table contains also the graphs presenting the Ct values of the
samples along the calibration curve (robust regression) for each
assay.
6. Statistical Analysis
The Affymetrix probe level data were summarized using
FARMS (Factor Analysis for Robust Microarray Summarization).
Raw intensities were log2 transformed to get data normally
distributed. First, an unsupervised multivariate projection method,
Spectral Map Analysis, was applied to reduce the complexity of
highly dimensional data (n genes versus p samples). Spectral Map
Analysis provides an unbiased identification of the predominant
clusters of genes and subjects that are present in the data set.
Second, we modeled the expression data in LIMMA (Linear
Models for Microarray Data) [23), a method that is designed to get
reliable analyses even for experiments with small number of
arrays. In LIMMA, we used a model that includes the three
dichotomous factors of cellular origin (anti-CD31 cells versus anti-
alpha smooth muscle actin cells), tissue origin (aorta versus DA),
and time (day 18 versus day 21), as well as all two-way interactions
between these factors. In this model, we performed tests for
differential gene expression between the two cellular origins.
Third, differences between DA and aorta in expression profiles
over embryonic age were investigated by testing for the presence of
a two-way interaction of tissue origin and time, using the same
model in LIMMA. Models like LIMMA assume that all the
samples have been randomly and independently collected. In all
our LIMMA analyses, we tested for the differences corresponding
to each factor both globally over all samples to obtain increased
power, but also separately for subsets of the samples corresponding
to specific values of the other factors, to be able to detect whether
effects are consistent for different values of the other factors. We
corrected each of the analyses separately for multiple testing, using
the false discovery rate (FDR) and corrected all p-values for
multiplicity. Multiplicity-adjusted p-values below 0.05 were
considered significant. The complete set of data is available in
the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE51248).
7. Immunohistochemistry (see Figure S3)
Immunohistochemistry was used as a qualitative technique to
confirm protein expression in tissue sections. By rigorously
standardizing the methodology (simultaneous staining of sections
using the same aliquots, timing and temperature) we were able to
validate differences in staining intensity between sections, albeit
not the degree of difference.
The experiments were performed on sections from 4%
paraformaldehyde fixed tissue routinely processed for paraffin
immunohistochemical investigation. Primary antibodies against
Rgs5 (Santa Cruz Biotechnology, CA, USA, SC-28492) 1:200–
1:400, Pcp4 (Santa Cruz Biotechnology,CA, USA, SC–98549)
1:200–1:400, DLX-1 (Aviva Systems Biology, San Diego, CA,
ARP32866) 1:1000, Tcfap2B (Abcam, Cambridge, MA, USA
ab18113) 1:200 were used. The primary antibodies were
dissolved in phosphate buffered saline (PBS) with 0.05%
Tween-20 and 1% bovine serum albumin (BSA, Sigma Aldrich,
USA). Slides were incubated overnight. Between subsequent
incubation steps all slides were rinsed two times in PBS and
once in PBS/Tween-20. The slides were incubated with
secondary antibodies for 45 min: for RGS 5 with biotinylated
horse anti -goat (H+L) (Vector laboratories, USA BA–9500),
1:200 and 1:66 normal horse serum (Brunschwig Chemie,
Switzerland, S-2000), for PCP4 and DLX1 with biotinylated
goat anti-rabbit (H+L) (Vector Laboratories, USA, BA-1000),
1:200, for TCFAP2B with biotinylated horse anti-mouse (H+L)
(Vector Laboratories, USA, BA-2000), 1:200 and 1:66 normal
horse serum (Brunschwig Chemie, Switzerland, S-2000). The
slides were incubated with ABC-reagent (Vector Laboratories,
USA, PK-6100) for 45 min. For visualization the slides were
incubated with 400 mg/ml 3-39di-aminobenzidintetrahydrochlor-
ide (DAB, Sigma-Aldrich Chemie, USA, D5637) dissolved in
Tris-maleate buffer pH 7.6 to which 20 mlH2O2 was added for
8 minutes. Counterstaining was performed with 0.1% haema-
toxylin (Merck, Darmstadt, Germany) for 5 sec., followed by
rinsing with tap water for 10 min. All slides were dehydrated
and mounted with Entellan (Merck, Darmstadt, Germany).
Results
First we explored the microarray data of all 48 samples by
the unsupervised spectral map analysis (SPM). This analysis
revealed differences between the 24 samples from day 18 and
the 24 samples from day 21 (Figure 3a). The SPM bioplot
illustrates the results of this unsupervised analysis. The first
Dlx1 and Rgs5 in the Ductus Arteriosus
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component of the principal component analysis explained 29%
of the total variance in the dataset of the 11484 genes that were
reliably detected, and separated the samples from day 18 from
those from day 21. The second component explained 10% of
the total variance and separated ECs from SMCs. Next we
analyzed the dataset with a supervised test. With the linear
model for microarray data analysis (LIMMA) (P-values ,0,05
adjusted for multiple testing using the False Discovery Rate
(FDR) we compared all samples by gestational age (i.e., day 18
versus day 21), by cell type (i.e., ECs versus SMCs) and by
vascular origin (i.e., DA versus aorta). LIMMA confirmed the
strong age-dependency of the gene expression detected by the
unsupervised test. In the gene-by–gene analysis 3239 genes were
differentially expressed between the 24 samples from day 18
and the 24 samples from day 21. Compared to other factors
such as cell type and vascular origin gestational age had the
largest effect on the distribution of the data.
Comparing ECs and SMCs we found differential expression of
858 genes in the gene-by-gene analysis. Examples include well-
known endothelial-specific genes such as tyrosine kinase with
immunoglobulin-like and EGF-like domains 1 (Tie1), endothelial
tyrosine kinase, (Tek), platelet/endothelial cell adhesion molecule 1
(Pecam1) and von Willebrand factor (Vwf). (see Figure S4) The latter
was found to be the highest upregulated gene (5.1 logfold) in ECs
(adjusted p-value 1.8e-06) in the LIMMA analysis. The upregula-
tion of Vwf was also validated by rtqPCR confirming that the
LCM procedure was successful for the enrichment of EC (see
Figure S4).
The comparison between the DA and the aorta revealed 16
genes that were differentially expressed between both vessels
(Figure 3b). Five out of these 16 genes were significantly
upregulated in the aorta. Among these genes Pcp4 showed the
highest (3.2 log-fold, adj. p,0.001) and the most significant
upregulation. Out of the 9 genes that were upregulated in the DA
Figure 3. Visual representation of microarray results. A. Spectral map bioplot. The first two principal components (PC) of the weighted
spectral map analysis (SPM) of normalized microarray data are plotted. The samples are depicted in coloured squares with numbers. The colours are
explained in the figure. AO SMC= smooth muscle cells from the descending aorta, DA EC= endothelial cells from the ductus arteriosus, DA
SMC= smooth muscle cells from the ductus arteriosus. 18 d=day 18 of gestation, 21 d= day 21 of gestation. Distances between the squares are a
measure for the similarity between samples. Genes that do not contribute to the differences are indicated as dots in the cloud around the centroid
(represented by the cross). The ten most significantly contributing genes are annotated by their gene symbol. The first PC (PC1) explains 29% of the
variance in the dataset and discriminates samples from day 18 (n = 24) from those of day 21 (n = 24). The second PC (PC2) explains 8% of the variance
and discriminates between ECs and SMCs. B. Histogram showing the most significant differentially expressed genes between DA and aorta. The
annotation of the genes is on the x-axis. The adjusted p-values are on the y-axis. Red bars represent genes that are enriched in the aorta. Green bars
represent genes that are upregulated in the DA. C. Volcano plot. The volcano plot constructed with LIMMA analysis summarizes the fold changes
between the two types of the samples (i.e., DA versus aorta) and the log10 transformed p-values. The negative log10 transformed p-values (y-axis) are
plotted against the log ratios between the samples (log2 fold change). For our study we selected 4 genes. The position in the upper left (Rgs5, Tfap2B,
Dlx1) is the result of a high ratio of differential expression.
doi:10.1371/journal.pone.0086892.g003
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Rgs5 (3.1 log-fold, adj. p = 0.045) had the highest expression level.
Table 1 lists the 16 genes alphabetically. Volcano plots are
provided (Figure 3c and Figure S5). The volcano plot (Figure 3c)
shows the comparison between DA and aorta in all 48 samples.
From this plot we selected four genes (Rgs5, Dlx1 and Tfap2B in the
DA and Pcp4 in the aorta) for further study. These four genes were
found in the left (Pcp4) or right (Rgs5, Dlx1, Tfap2B) upper part of
the plot.
Rgs5
Rgs5 was identified as a DA-enriched gene by the microarray.
LIMMA revealed a significant upregulation of Rgs5 in all four cell
types of the DA at both time points (Figure 4a) showing higher
expression levels at day 21 as compared to day 18. To confirm the
findings we performed rtqPCR analyses (Figure 5a). Using a
validated fluorogenic TaqManH gene expression array (Ppib
normalized) we confirmed the upregulation of Rgs5 in the DA in
comparison to the aorta. The highest relative expression of Rgs5
was found in the SMCs of the DA at day 21. At day 18 RGS5 was
significantly less expressed in the SMC of the DA confirming also
the strong age-dependency of this gene in the DA. ECs of the DA
expressed comparably low levels of Rgs5 at day 18 and 21. In the
aorta Rgs5 was below the detection level in both cell types at day
18 and remained at a very low level at day 21.
Dlx1
Dlx1 was detected as a DA-enriched gene by the microarray.
Globally Dlx1 exhibited a 1.75 log-fold upregulation in the cells
of the DA when compared to the cells from the aorta
(Figure 4b). The highest expression levels of Dlx1 were found
in SMCs of the DA (Figure 4b). The upregulation in the DA
was significant in both cell types at both time points. RtqPCR
analysis (Ppib normalized) confirmed the upregulation of Dlx1
expression in the DA (Figure 5b). The clear expression
difference was present in all cell types. Dlx1 was virtually
absent in aortic ECs of both gestational ages and in aortic
SMCs of day 21 (0.3–0.4 fold-difference). In the DA at day 18
and day 21 both ECs and SMCs had a high magnitude of Dlx1
expression (ranging between 24 and 84 fold-difference). An
increase of the expression levels with gestational age was present
in the SMCs but not detected in ECs.
Tfap2B
Tfap2B was selected because of its differential expression
between DA and aorta shown in the volcano-plot (Figure 4c).
An upregulation of Tfap2B was documented in both cell types of
the DA at both time-points (Figure 4c) showing higher expression
levels at day 21 as compared to day 18. Using a validated
fluorogenic TaqManH gene expression array (Ppib normalized), we
confirmed the ductus-specific expression in ECs en SMCs at day
18 and day 21 (Figure 5c). Differences between the expression
levels in the SMC and the EC of the DA were not significant. In
cells from the aorta Tfap2B expression was below or just slightly
above detection level.
Pcp4
Pcp4 was recognized as an aorta-enriched gene with the
highest and most significant level of differential expression
between aorta and DA by LIMMA in ECs and SMCs at both
time points (Figure 4d). Furthermore, the expression level of
Pcp4 was higher in all samples from day 21 as compared to day
18. LIMMA analysis also revealed the significant upregulation
in the aorta (log-fold 3.2, adj. P,0.001) globally and also
separately for gestational age and cell type. Because of its high
and significant upregulation in the aorta, we selected Pcp4 for
confirmatory rtqPCR. The validated fluorogenic TaqManH gene
expression array (Ppib normalized) also showed an upregulation
of this gene in the aorta compared to the DA (Figure 5d). The
Table 1. The 16 most significantly differentially expressed genes between DA and aorta in alphabetical order.
Probe set ID Gene Name (UniGene) Symbol LogFC p -value
Affymetrix DA:Ao
25203_at Cyclin B1 Ccnb1 0.587 ,0.050
294864_at Chaperonin containing TCP1 Cct5 0.509 ,0.045
304021_at Collagen type 8 alpha Col8a1_predicted 22.081 ,0.001
296500_at Distal-less homeobox1 Dlx1 1.741 ,0.050
85246_at Growth arrest specific protein 7 Gas7 20.676 ,0.021
29199_at Hemochromatosis gene Hfe 0.426 ,0.050
316758_at Laminin alpha 1 Lama1 1,42 ,0.050
1383708_at Integrin, beta-like protein 1 (Itgbl1) LOC498564 22.216 ,0.050
1378988_at mab-21-like 2 LOC680102 0.947 ,0.050
293652_at NADH dehydrogenase (ubiquinone) Fe-S protein 8 Ndufs8_predicted 0.573 ,0.045
25510_at Purkinje cell protein 4 (also known as neuron specific protein PEP-19) Pcp4 23.185 ,0.001
295401_at Lipidphosphate phosphatase-related protein type 4 (LPPR4) Prg1 20.753 ,0.050
295284_at RNA binding motif protein 8A Rbm8_predicted 0.388 ,0.050
1372066_at Family with sequence similarity 103, member A1 RGD1310022 0.709 ,0.045
54294_at Regulator of G-protein signaling 5 Rgs5 3.075 ,0.050
296883_at Replication protein A3 Rpa3_predicted 0.642 ,0.045
Probe set identification numbers (ID Affymetrix) of the GeneChip Rat Genome 230.20 Array, gene name according to UniGene, gene symbols, logfold changes (logFC)
between DA and aorta and the adjusted p-values are shown.
doi:10.1371/journal.pone.0086892.t001
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highest and most significant upregulation (10 fold-difference)
was found in the ECs of the aorta at day 21 while the
magnitude of expression was only 2 fold increased in aortic ECs
at day 18. SMCs of the aorta did not show an increase of Pcp4
expression with gestational age. In all samples of DA cells
relative Pcp4 expression was detected at very low levels (0.3–0.7
fold difference) confirming the microarray data.
Discussion
DA maturation and closure is regulated by the interaction of
many genes in different cell types. We performed a genome-wide
microarray analysis searching for genes that are differentially
expressed between DA and aorta of fetal rats at day 18 and day 21.
Laser-capture microdissection was used to isolate ECs and SMCs
as an efficient and precise method for the sampling of single cells
or subgroups of cells in heterogeneous tissues. [24] This selective
approach minimizes the noise of the microarray introduced by the
variation in tissue composition. [25] We selectively amplified
mRNA from ECs and SMCs from DA and aorta and intentionally
did not pool the various samples. Analysis of the microarray data
revealed for the most part DA- and aorta-enriched genes that were
not detected in former studies [19,20] in which microarrays of the
complete wall of the aorta were performed. Among 16 differen-
tially expressed genes between DA and aorta detected by LIMMA,
this study for the first time identified Rgs5 and Dlx1 as molecular
markers of the DA in the fetus. Together with Pcp4, the most
significant aorta-enriched gene in our analysis, and Tfap2B these
genes were studied more extensively with other techniques. In all
analyses a significant time-dependency for Rgs5, Dlx1 and Pcp4 was
observed. This strengthens the initial observation that gestational
age had the largest influence on the differential gene expression
between all samples.
The small overlap in detected genes between the current study
and former studies is not surprising as differences are unavoidable
when comparing transcriptional profiles by the microarray
technique as Coceani et al. [21] emphasized commenting on the
large variance between two former studies. [19,20] Therefore it
was suggested that any such comparison should consider cohorts
of genes for distinct functions rather than single genes. [21] The
current selective microarray study enables us to discuss single
genes that were most significantly differentially expressed between
ECs and SMCs in DA and aorta.
Rgs5 is enriched in ECs and SMCs of the DA with a
maturation–state dependent increase in expressionlevelbetween-
day18 to day 21. Rgs5 is coding for a protein regulating the
function of vasoactive G-protein coupled receptors (GPCRs). [26]
Many GPCRs are active during fetal maturation and postnatal
closure of the DA such as EP2, 3, 4 [27], angiotensin [19] and ET-
1 receptors. [28] Rgs5 is the most highly and differently expressed
Rgs-R4 subfamily member in arterial smooth muscle, suggesting
that Rgs5 is a candidate for regulating arterial contractility,[29]
Figure 4. Gene expression of Rgs5 (a), Dlx1 (b), Tfap2B (c) and Pcp4 (d) by microarray. Expression levels are expressed as fluorescent signal
intensity measured on the array after normalization. The dots represent individual samples. Horizontal bars represent the means. The same colors are
used in a–d. Red= ECs from the aorta at day 18 (AO EC 18), yellow=ECs from the aorta at day 21 (AO EC 21), light green= SMCs from the aorta at day
18 (AO SMC 18), dark green= SMCs from the aorta at day 21 (AO SMC 21), turquoise = ECs from the DA at day 18 (DA EC 18), blue = ECs from the DA at
day 21 (DA EC 21), purple = SMCs from the DA at day 18 (DA SMC 18), pink = SMCs from the DA at day 21).
doi:10.1371/journal.pone.0086892.g004
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probably under control of platelet-derived growth factor (PDGF)
that represses RGS5. [26] Rgs5 is downregulated in pericytes and
vascular smooth muscle cells of Pdgf null mice. [30] The
maturation–dependent upregulation of this DA-enriched gene in
the newborn was not categorized in the fetal cohort. [19] Recently
it was shown that the homogeneous Rgs5 expression in the aorta
of neonatal mice changed into a mosaic pattern in adult animals.
[31] The lowest expression levels were found in the ascending
aorta and carotid arteries. Interestingly a localized high Rgs5
expression was documented at the site of the former DA insertion
[31] suggesting that an origin-specific epigenetic program resulting
in differential Rgs5 promoter methylation is involved in the
regulation of Rgs5 expression. The DA SMCs derive from neural
crest cells populating the 6th pharyngeal arch, while the SMCs
from the descending aorta are derived from the adjacent somites.
We did not study the role of epigenetic factors causing differential
Rgs5 promoter methylation as shown in mice [31].
Microarray analysis also revealed Dlx1 as a DA-enriched gene.
It discriminates the DA from the aorta at day 18 and day 21 and is
highly enriched in both ECs and SMCs of the DA as documented
by quantitative rtPCR. This is a novel finding, Costa et al. [19]
and Jin et al. [20] did not identify upregulation of Dlx1 in the DA.
Dlx1 is part of a subfamily of vertebrate homeobox-containing
genes that are structurally similar to the Drosophila distal-less gene.
Dlx1 plays a role in the development of pharyngeal arch elements
including jaws and teeth. Furthermore it is active during
neurogenesis in the forebrain. [32] In addition Dlx genes have
been detected in several cancer cell lines [33] where deregulation
of Dlx genes was related with tumor progression. [33] Dlx1 and 2
are expressed in the embryonic caudal pharyngeal arch complex
where the ductus arteriosus develops. [34] This is also the case for
two other homeobox gene families (Msx and Prx] that interact with
Dlx. [35] Interestingly, Prx2 is enriched in developing chicken DA
while Prx1 is enriched in the adjoining vessel parts. [36] The loss of
function of both genes in gene-targeted mice results in DA
malformations. [37] The interactions between Msx, Prx2 and Dlx1
genes in DA development have yet to be elucidated. In addition to
its role in embryogenesis DLX1 has been reported in hematopoi-
etic cells [38] as a regulator of multiple signals from TGF-beta
superfamily members. [39] DLX2 the counterpart of DLX1 in the
bigene cluster is expressed depending on reactive oxygen species
(ROS) in response to glucose deprivation. [40] Based on our data
and the information from other biological contexts we propose
that Dlx1 is involved in late gestational vascular remodeling of the
DA.
Because of the significant upregulation of Tfap2B in the DA in
our microarray experiment we selected this gene for further
validation by rtqPCR. The AP-2B transcription factor is involved
in the regulation of SMC development in the DA in mice. [17]
Acting in a transcriptional network with ET-1 and HIF2a Tfap2B
is shown to be relevant for proper ET-1 signaling in the DA. [17]
Therefore it has been suggested that patent DA in Tfap2B deleted
animals could partly be attributed to the lack of ET-1 signaling.
Recently Zhao et al. [18] described the phenotype of Tfap2B
knockout mice and documented Bmp2 and Bmp4 as downstream
targets of Tfap2B. These mice are characterized by a PDA,
postaxial accessory digits and enhanced apoptotic cell death of
renal epithelial cells. [18,41] Interestingly, DLX1 directs the
expression of BMP4 in various biological contexts. [39] The
upregulation of both transcription factor genes Dlx1 and Tfap2 B
Figure 5. Gene expression of Rgs5 (a), Dlx1 (b), Tfap2B (c) and Pcp4 (d) by rtqPCR. The same mRNA preparations were used for microarray
(shown in figure 4) and rtqPCR. Relative expression levels are shown for each sample. Horizontal bars depict the means. The levels are
peptidylprolylisomerase B (Ppib) normalized. Red symbols represent endothelial cells (EC) and green symbols represent smooth muscle cells (SMC).
AO= aorta, DA=ductus arteriosus. 18 =day 18, 21 = day 21.
doi:10.1371/journal.pone.0086892.g005
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in the DA suggests a vessel-specific regulation of Bmp4 signaling
during fetal DA remodeling.
Pcp4 was identified as the most significant aorta-enriched gene.
From day 18 to day 21 an increase in Pcp4 levels was observed
suggesting a biological function of Pcp4 in the aorta during this
period. However, the role of Pcp4 and its protein has not been
characterized sufficiently in the vascular system. Pep-19/pcp4-null
mice have been made. [42] Although these mice are viable and
fertile it cannot be ruled out that the maturation of the ductus
arteriosus is impaired. In humans and also in rats [8] a small DA
can persist with few haemodynamic consequences. Lacking a more
detailed description of the vascular system and the litter sizes [42],
perinatal mortality in these mice due to abnormal maturation of
the DA or aorta might have been missed.
Pcp4 has mainly been studied in neuronal tissues where it
regulates calcium/calmodulin interactions [43] and inhibits
calcium induced neuronal cell death by apoptosis. [44] By
analogy to the neuronal tissues we postulate that upregulation of
Pcp4 in the aorta might protect the aorta around birth against
apoptosis. Accordingly, the relatively lower expression of Pcp4 in
the DA might render the EC and SMC in the DA more
susceptible to apoptosis, which plays an important role in
postnatal DA closure. [5] Interestingly, a study on the
parturition of mice linked another apoptosis driven process –
the softening of the cervix at the end of gestation - with a
relative decline in Pcp4 expression in cervix tissue. [45] This
supports a role for Pcp4 as anti-apoptotic regulator. The results
of Jin et al. [20] are in concordance with our results and
categorized Pcp4 as aorta-enriched gene in the fetus. Costa et al.
[19] detected a postnatal upregulation of the same gene in the
DA in comparison to the aorta. Additionally a cluster of other
calcium-linked genes was identified in the neonatal DA, while
its postnatal upregulation was related to a modified calcium
homeostasis and increased drive of the DA to contraction. [19]
Our analysis of mRNA from ECs and SMCs from fetal DA did
neither identify Pcp4 nor one of the other members of the
cluster of calcium-linked genes described in the neonatal DA.
In conclusion, our study confirms a DA-specific transcriptional
profile in ECs and SMCs and thereby offers a basis to unravel the
molecular regulation of fetal DA maturation. For the first time we
recognized Rgs5 and Dlx1 as DA-enriched genes. These genes
represent novel molecular targets for the regulation of fetal DA
maturation and postnatal DA closure.
Supporting Information
Figure S1 Visual representation of microarray results
of the pilot experiment. A: Spectral map bioplot of samples of
day 21 in the independent pilot experiment. The first principal
components (PC) of the weighted spectral map analysis (SPM) of
normalized microarray data are plotted. Colored squares with
numbers depict different samples, while circles depict genes.
Distances between the squares are a measure for similarity
between samples. Genes that do not contribute to the differences
between the samples are indicated as dots in the cloud around the
centroid (represented by the cross). The ten most significantly
contributing genes to the differences between samples are
positioned in the largest distance from the centroid and annotated
by their gene symbol. PC1 represented on the x-axis explains 28%
of the variance of the dataset and discriminates between DA and
aorta. PC2 represents 13% of the variance and discriminates
between ECs and SMCs. Note Vwf among the genes that
contribute to this difference. B: Volcano plot of the pilot
experiment. Differential expression between samples of SMC of
the DA and the aorta at day 21. The volcano plot constructed with
LIMMA analysis summarizes the fold changes between the two
types of samples (i.e., DA versus aorta) and the log 10 transformed
p-values. The negative log 10 transformed p-values (y-axis) are
plotted against the log ratios between the samples (log2 fold
change). From the four selected genes of our study Dlx1 and Rgs5
are found in the upper left of the plot. C: Volcano plot of the pilot
experiment. Differential expression between EC of the DA and
aorta. Dlx1 (upper left) and Pcp4 (upper right) both show a high
ratio of differential expression in combination with a high
significance level.
(TIF)
Figure S2 Gene expression of Rgs5, Dlx1, Pcp4, and
Tcfap2B at day 21 (pilot experiment). Gene expression of
Rgs5 (a), Dlx1 (b), Pcp4 (c), and Tcfap2B (d) at day 21 by
microarray in the independent pilot experiment using 4 DA and 4
aorta samples. One DA sample was excluded because of mRNA
degradation. Expression levels are expressed as fluorescent signal
intensity measured on the array after normalization. Expression
levels are shown for individual samples. The colors are the same as
in figure S1 The colored horizontal lines represent the means.
(TIF)
Figure S3 Protein expression of RGS5, DLX1 and PCP4
by immunohistochemistry. Photomicrographs of representa-
tive transverse sections show (a,b) RGS5 (c,d) DLX1 and (e,f)
PCP4 expression in DA and aorta. The DA (a) shows a more
intense cytoplasmatic staining against RGS5 in ECs and SMCs
than the aorta (b). This is most clearly seen in the EC and the
subendothelial layer of SMCs which were also studied in the
microarray experiment. Dlx1 is predominantely expressed in the
DA (c) where EC and the innermost layers of SMC show the most
intense staining. The EC in the aorta (d) are almost negative for
DLX1. PCP4 is predominantely expressed in the aorta (f) the DA
(e) shows less stained nuclei of the ECs of the aorta. In comparison
with the aorta (f) the DA (e) shows less stained nuclei and
cytoplasm of ECs and SMCs. Scale bars 100 mm.
(DOCM)
Figure S4 Vwf gene expression results. Gene expression of
von Willebrand Factor (Vwf) by microarray and RT-PCR.
Expression levels are expressed as fluorescent signal intensity
measured on the array after normalization (a). Expression levels
are shown for individual samples. The colors correspond to the
colors used in figure 1. The colored horizontal lines represent the
means. Black dots represent samples that are not reliably detected.
Note the high expression level of Vwf in all EC samples. The graph
(b) shows the relative quantification of mRNA of Vwf by
quantitative RT-PCR (qRT-PCR) normalized with PGK1. The
red symbols represent EC, the green SMC. All individual samples
are presented. The horizontal lines indicate the means. The same
mRNA preparations were used for microarray and the qRT-PCR.
The PCR results confirm the microarray results by showing a high
relative expression of Vwf in EC while its mRNA is just above
detection level in SMC of the aorta.
(TIF)
Figure S5 Separate volcano plots for each cell type and
gestational age. Volcano plots constructed with LIMMA
analysis plotted separately for (a) EC at day 18, (b) SMC at
day 18, (c) EC at day 21 and (d) SMC at day 21. The four
selected genes Rgs5, Dlx1, Tcfap2B and Pcp4 are all identified with
high ratios of differential expression in combination with a high
significance level in (a) and partly in (b,c,d).
(TIF)
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Table S1 Two-round linear mRNA amplification yield.
RNA yields of amplified RNA (aRNA) and biotin-labeled
antisense mRNA (cRNA). Chip ID=Chip identification number,
Individual samples are described by a four-digit number followed
by a capital letter, sample site, cell type and gestational age.
Aorta = descending aorta, DA= ductus arteriosus, EC= endothe-
lial cells, SMC= smooth muscle cells, 18 d= 18 days, 21 d= 21 d.
(DOC)
Table S2 RtqPCR assay details. This table contains the
parameters derived by linear and robust regression of the pre-
designed assays (Applied Biosystems) that were used for quanti-
tative rt-PCR. The calibration curves obtained by robust
regression are also represented in this supplementary table. All
validated Applied Biosystems assays for Dlx1 will detect sequences
59 upstream of the 39 sequence detected by the Affymetrix
microarray probes. Therefore, specific primers/probe against this
39 sequence were designed.
(XLS)
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